Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index; 2 of the 3 sources its claims cite were checked for support.

Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients

Open access

Abstract

An integrated diagnostic approach using FNA cytology, ZN staining, auramine O, GeneXpert MTB/RIF and RT-PCR was evaluated against culture in suspected tuberculous lymphadenitis.

Overview

CoChat Summary

## TL;DR

This cross-sectional study of 96 clinically suspected tuberculous lymphadenitis (TBLN) patients found that FNAC and RT-PCR detected more cases than smear microscopy, and that combining FNAC with molecular tests improved diagnostic yield. The best-performing combined approach was FNAC plus GeneXpert MTB/RIF on concentrated FNA samples, which reached 100% sensitivity versus LJ culture.

## Key findings

  • Among 96 FNA samples, detection rates were 12.5% by Ziehl-Neelsen (12/96), 28.1% by Auramine O (27/96), 53.2% by FNAC (51/96), 44.7% by GeneXpert MTB/RIF (43/96), 53.1% by RT-PCR (51/96), and 37.5% by LJ culture (36/96).
  • Using LJ culture as the gold standard, sensitivities were 91.7% for GeneXpert MTB/RIF, 97.2% for RT-PCR, and 97.2% for FNAC; specificities were 83.3%, 73.3%, and 68.3%, respectively.
  • Combining GeneXpert MTB/RIF and RT-PCR with FNAC detected 61 cases (63.5%) and yielded 100% sensitivity; specificity for the combined approach was 58.3%.
  • Among culture-positive cases, the average LJ growth time was 3 to 6 weeks, and 4 samples were contaminated and excluded from analysis.

## Methods

  • Cross-sectional study of 96 clinically diagnosed TBLN-suspected patients enrolled at ALERT Hospital in Addis Ababa between September 2020 and April 2021.
  • Fine needle aspirate (FNA) samples were tested by FNAC, Ziehl-Neelsen staining, Auramine O staining, GeneXpert MTB/RIF, RT-PCR targeting IS1081, and LJ culture after concentration/decontamination of samples.
  • Diagnostic performance was assessed against LJ culture using sensitivity, specificity, PPV, NPV, and Cohen’s kappa; analyses were done in SPSS 26.

## Limitations

  • The paper states that culture was slow and that some FNA samples were mixed with blood, which “might have contributed” to lower GeneXpert positivity; this is an evident sample-quality limitation.
  • Four samples were contaminated and excluded from analysis, which may have reduced the effective sample size; this is evident from the text.
  • The study was conducted in one hospital with 96 patients, so generalizability is limited; this is evident from the study design and sample.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0265499

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

2 Valid · 0 Not valid · 0 Not checked · 62 Own results and interpretations

39 more claims

Create a free account to see all 64 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 14
  • Probably not a substantial claim. 7
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Self-check results appear here once an independent check has confirmed them.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

1 of 1

Citations

Cites

1 retracted

Show all 25 references

Cited by

See all 6

Metadata

Authors
Atnafu, A., Desta, K., Girma, S., Hailu, D., Assefa, G., Araya, S., Bekele, D., Wassie, L., & Bobosha, K.
Affiliations
  • Armauer Hansen Research Institute (ET)
  • Addis Ababa University (ET)
Corresponding author
Atnafu, Abay
Venue
PLoS ONE
Published
2022-03-31
Volume
17
Issue
3
Pages
e0265499
ISSN
1932-6203 (ISSN-L)
OpenAlex
W4220853009
Cited by
6
References
25
Citations by year
2025: 3 · 2024: 2 · 2023: 1
FWCI
0.76
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Greater South Information System
Funders
  • Styrelsen för Internationellt Utvecklingssamarbete
  • Direktoratet for Utviklingssamarbeid
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphadenopathy Diagnosis and Analysis
Keywords
tuberculous lymphadenitis, Mycobacterium tuberculosis detection, fine needle aspiration cytology, Xpert MTB/RIF, RT-PCR, Ziehl-Neelsen staining, auramine O staining, Lowenstein-Jensen culture, sensitivity and specificity, integrated diagnostic approach, resource-limited settings, interobserver agreement, predictive value, unnecessary antibiotic use
MeSH terms
Cross-Sectional Studies, Humans, Mycobacterium tuberculosis, Sensitivity and Specificity, Tuberculosis, Lymph Node, Biopsy, Fine-Needle

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients. https://app.cochat.ai/papers/10.1371/journal.pone.0265499
The paper
Atnafu, A., Desta, K., Girma, S., Hailu, D., Assefa, G., Araya, S., Bekele, D., Wassie, L., & Bobosha, K. (2022). Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients. PLoS ONE. https://doi.org/10.1371/journal.pone.0265499

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.